Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 1, 2012, Pages 193-201

  Jones, Michelle L ^a   Ewing, Charles M ^a   Isaacsa, William B ^a   Getzenberg, Robert H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenin; Cancer; Fibroblasts; Invasion; Prostate

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; CYTOKINE; PANCREATIC RIBONUCLEASE; SMALL INTERFERING RNA;

ARTICLE; CANCER INVASION; CELL CULTURE; CELL MOTION; CULTURE MEDIUM; DRUG EFFECT; FIBROBLAST; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE;

ANGIOGENESIS INDUCING AGENTS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN TYPE I; CULTURE MEDIA, CONDITIONED; CYTOKINES; FIBROBLASTS; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATE; PROSTATIC NEOPLASMS; RIBONUCLEASE, PANCREATIC; RNA, SMALL INTERFERING;

EID: 84855183561     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01283.x     Document Type: Article

References (35)

1. nd ed. New York : Wellness Central; 2007.
2. Schoenstadt A. Prostate cancer survival rates. eMedTV. 2006. (accessed 12 May 2010).
3. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol. 2005; 173: 10-20.
4. Olumi AF, Grossfeld GD, Hayward SW, et al Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999; 59: 5002-11.
5. Kirschenbaum A, Wang J-P, Ren M, et al Inhibition of vascular endothelial cell growth factor suppresses thein vivogrowth of human prostate tumors. Urol Oncol: Semin Original Invest. 1997; 3: 3-10.
6. Dow JK, deVere White RW. Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology. 2000; 55: 800-6.
7. Gleave M, Hsieh JT, Gao CA, et al Acceleration of human prostate cancer growthin vivoby factors produced by prostate and bone fibroblasts. Cancer Res. 1991; 51: 3753-61.
8. Nakashiro K, Okamoto M, Hayashi Y, et al Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. Am J Pathol. 2000; 157: 795-803.
9. Camps JL, Chang SM, Hsu TC, et al Fibroblast-mediated acceleration of human epithelial tumor growthin vivo. Proc Natl Acad Sci USA. 1990; 87: 75-9.
10. Djakiew D, Pflug BR, Delsite R, et al Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res. 1993; 53: 1416-20.
11. Gmyrek GA, Walburg M, Webb CP, et al Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am J Pathol. 2001; 159: 579-90.
12. Nishimura K, Kitamura M, Miura H, et al Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction. Prostate. 1999; 41: 145-53.
13. Tuxhorn JA, Ayala GE, Smith MJ, et al Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res. 2002; 8: 2912-23.
14. Jackson RS, 2nd, Franco OE, Bhowmick NA. Gene targeting to the stroma of the prostate and bone. Differentiation. 2008; 76: 606-23.
15. th ed. New York : Garland Science; 2002.
16. Katona TM, Neubauer BL, Iversen PW, et al Elevated expression of angiogenin in prostate cancer and its precursors. Clin Cancer Res. 2005; 11: 8358-63.
17. Kawada M, Inoue H, Arakawa M, et al Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin. Cancer Sci. 2007; 98: 350-6.
18. Karaca B, Kucukzeybek Y, Gorumlu G, et al Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol. Eur Cytokine Netw. 2008; 19: 176-84.
19. Hu G, Riordan JF, Vallee BL. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci USA. 1994; 91: 12096-100.
20. Fujita K, Ewing CM, Sokoll LJ, et al Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation. Prostate. 2008; 68: 872-82.
21. De Wever O, Hendrix A, De Boeck A, et al Modeling and quantification of cancer cell invasion through collagen type I matrices. Int J Dev Biol. 2010; 54: 887-96.
22. Donat SM, Genega EM, Herr HW, Reuter VE. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol. 2001; 165: 1117-20.
23. Hara I, Yao A, Muramaki M, et al Stromal invasion of the prostate following a complete response to bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the ureter and the bladder. Int J Urol. 2004; 11: 250-2.
24. Fukumura D, Xavier R, Sugiura T, et al Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998; 94: 715-25.
25. Paland N, Kamer I, Kogan-Sakin I, et al Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in anin vitrococultivation model of prostate cancer. Mol Cancer Res. 2009; 7: 1212-23.
26. Hu GF, Strydom DJ, Fett JW, et al Actin is a binding protein for angiogenin. Proc Natl Acad Sci USA. 1993; 90: 1217-21.
27. Hu GF, Chang SI, Riordan JF, et al An angiogenin-binding protein from endothelial cells. Proc Natl Acad Sci USA. 1991; 88: 2227-31.
28. Li WY, Chong SS, Huang EY, et al Plasminogen activator/plasmin system: a major player in wound healing? Wound Repair Regen. 2003; 11: 239-47.
29. Suzuki Y, Someki I, Adachi E, et al Interaction of collagen molecules from the aspect of fibril formation: acid-soluble, alkali-treated, and MMP1-digested fragments of type I collagen. J Biochem. 1999; 126: 54-67.
30. Olson KA, Byers HR, Key ME, et al Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res. 2001; 7: 3598-605.
31. Olson KA, Byers HR, Key ME, et al Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer. 2002; 98: 923-9.
32. Olson KA, French TC, Vallee BL, et al A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res. 1994; 54: 4576-9.
33. Olson KA, Fett JW, French TC, et al Angiogenin antagonists prevent tumor growthin vivo. Proc Natl Acad Sci USA. 1995; 92: 442-6.
34. Yoshioka N, Wang L, Kishimoto K, et al A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci USA. 2006; 103: 14519-24.
35. Majumder PK, Yeh JJ, George DJ, et al Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc Natl Acad Sci USA. 2003; 100: 7841-6.